News from Boston Scientific A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 08, 2017, 16:15 ET New Societal Guidelines Recommend Subcutaneous Implantable Cardioverter-Defibrillator for Patients with Ventricular Arrhythmias at Risk of Sudden Cardiac Death

Updated guidelines issued by the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) now...


Oct 23, 2017, 16:00 ET Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2017

Boston Scientific (NYSE: BSX) today announced key data that will be presented at the 29th Transcatheter Cardiovascular Therapeutics (TCT),...


Sep 19, 2017, 09:24 ET Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE)...


May 12, 2017, 12:23 ET Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) today announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from...


May 11, 2017, 13:02 ET Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients

Boston Scientific (NYSE: BSX) today announced results from the U.S. post-market approval study evaluating 'real-world' patients implanted with the...


Apr 18, 2017, 16:15 ET Boston Scientific Initiates Global Study To Assess Sudden Cardiac Arrest Prevention Therapy In Patients With Diabetes Who Have Previously Experienced A Heart Attack

Boston Scientific (NYSE: BSX) has initiated a worldwide study that will evaluate the survival benefit of patients treated with the EMBLEM™ MRI...


Nov 16, 2016, 16:30 ET Boston Scientific To Participate In Piper Jaffray 2016 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New...


Nov 16, 2016, 13:34 ET Boston Scientific Announces Positive Results Of HeartLogic™ Heart Failure Diagnostic Service

Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure...


Nov 02, 2016, 09:43 ET Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN™ Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device...


Oct 24, 2016, 16:30 ET Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2016

Boston Scientific (NYSE: BSX) today announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the...


May 03, 2016, 16:33 ET Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters

 Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the...


Apr 25, 2016, 16:30 ET Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for use in a...


Dec 09, 2015, 16:30 ET Voluntary Recall of Chariot™ Guiding Sheath

 Boston Scientific (NYSE: BSX) has voluntarily recalled the Chariot™ Guiding Sheath globally. These devices are intended for the...


Nov 30, 2015, 16:15 ET Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Boston Scientific (NYSE: BSX) has received United States (U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJet™...


Nov 19, 2015, 16:30 ET Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) today announced that the first implants of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device...


Nov 17, 2015, 08:30 ET Boston Scientific To Participate In Piper Jaffray 2015 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray 27th Annual Healthcare Conference on December 1, in New...


Nov 10, 2015, 08:30 ET Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences

Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a...


Oct 07, 2015, 17:00 ET Boston Scientific Launches Online Competition For New Digital Health Technologies

Boston Scientific (NYSE: BSX) this week announced the start of the Boston Scientific Connected Patient Challenge, an open innovation contest...


Oct 05, 2015, 06:30 ET Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

 Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer...


Sep 28, 2015, 07:00 ET Une nouvelle enquete devoile le veritable impact de l'asthme severe dans le quotidien des asthmatiques

L'asthme sévère retentit sur la vie professionnelle, sociale et familiale, et de nombreuses personnes déclarent qu'elles souffrent également...


Sep 28, 2015, 07:00 ET Un nuovo sondaggio rivela il vero impatto dell'asma grave sulle vite dei pazienti

La vita professionale, sociale e familiare è condizionata dall'asma grave; molti pazienti riferiscono anche sensazioni di ansia, depressione e...


Sep 28, 2015, 07:00 ET Neue Umfrage zeigt die tatsächlichen Auswirkungen von Schwerem Asthma auf das Leben von Patienten

Schweres Asthma beeinträchtigt Arbeits-, Sozial- und Familienleben, viele Patienten berichten von Angstgefühlen, Depressionen und...


Sep 28, 2015, 07:00 ET Una nueva encuesta revela el verdadero impacto del asma grave en la vida de las personas

Tanto el trabajo como la vida social y familiar se ven afectados por el asma grave; muchos pacientes refieren sentir ansiedad, depresión y...


Dec 12, 2014, 09:00 ET New Data Presented At NANS 2014 Demonstrate Long-Term, Low Back Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System

New retrospective data evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System...


Nov 19, 2014, 12:10 ET New Data From Evolve Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific (NYSE: BSX) SYNERGY™ Everolimus-Eluting...